(Q33230782)

24 July 2017

1 reference

title

Therapeutic strategies for ovulation induction in infertile women with polycystic ovary syndrome (English)

1 reference

polycystic ovary syndrome

24 July 2017

1 reference

1 reference

Paolo Giovanni Artini

3

0 references

author name string

Francesca Cristello

1

1 reference

PubMed ID

16390783

24 July 2017

Vito Cela

2

1 reference

PubMed ID

16390783

24 July 2017

Andrea Riccardo Genazzani

4

1 reference

24 July 2017

1 December 2005

1 reference

Gynecological Endocrinology

24 July 2017

1 reference

24 July 2017

21

1 reference

24 July 2017

6

1 reference

24 July 2017

340-352

1 reference

Epidemiology of infertility and polycystic ovarian disease: endocrinological and demographic studies

24 July 2017

1 reference

https://api.crossref.org/works/10.1080%2F09513590500463360

Polycystic ovaries--a common finding in normal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590500463360

Hyperandrogenaemia and the ovary.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590500463360

The importance of diagnosing the polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590500463360

Anovulation in eumenorrheic, nonobese adolescent girls born small for gestational age: insulin sensitization induces ovulation, increases lean body mass, and reduces abdominal fat excess, dyslipidemia, and subclinical hyperandrogenism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590500463360

Insulin sensitization early after menarche prevents progression from precocious pubarche to polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590500463360

Opposing influences of prenatal and postnatal weight gain on adrenarche in normal boys and girls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590500463360

Insulin sensitization for girls with precocious pubarche and with risk for polycystic ovary syndrome: effects of prepubertal initiation and postpubertal discontinuation of metformin treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590500463360

Evaluation of the quantitative insulin sensitivity check index as an estimate of insulin sensitivity in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590500463360

Mortality of women with polycystic ovary syndrome at long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590500463360

Relative risk of conversion from normoglycaemia to impaired glucose tolerance or non-insulin dependent diabetes mellitus in polycystic ovarian syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590500463360

Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590500463360

Dyslipidaemia is associated with insulin resistance in women with polycystic ovaries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590500463360

Polycystic ovaries in pre and post-menopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590500463360

Dyslipidaemia in polycystic ovarian syndrome: different groups, different aetiologies?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590500463360

Obesity, lipids, cardiovascular risk, and androgen excess

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590500463360

Ultrasound evaluation of PCO, PCOS and OHSS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590500463360

Ultrasound assessment of the polycystic ovary: international consensus definitions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590500463360

Comparison of follicular vascularization in normal versus polycystic ovaries during in vitro fertilization as measured using 3-dimensional power Doppler ultrasonography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590500463360

Laparoscopic treatment of polycystic ovaries with insulated needle cautery: a reappraisal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590500463360

Polycystic ovarian disease treated by laparoscopic argon laser capsule drilling: comparison of vaporization versus perforation technique

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590500463360

Review of nonsurgical and surgical treatment and the role of insulin-sensitizing agents in the management of infertile women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590500463360

Transvaginal ovarian drilling: a new surgical treatment for improving the clinical outcome of assisted reproductive technologies in patients with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590500463360

Clinical and hormonal characteristics of obese amenorrheic hyperandrogenic women before and after weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590500463360

New concepts in human sperm-zona pellucida interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590500463360

Weight loss in obese infertile women results in improvement in reproductive outcome for all forms of fertility treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590500463360

The role of lifestyle modification in polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590500463360

Metformin increases the ovulatory rate and pregnancy rate from clomiphene citrate in patients with polycystic ovary syndrome who are resistant to clomiphene citrate alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590500463360

Metformin therapy improves ovulatory rates, cervical scores, and pregnancy rates in clomiphene citrate-resistant women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590500463360

Co-administration of metformin during rFSH treatment in patients with clomiphene citrate-resistant polycystic ovarian syndrome: a prospective randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590500463360

A randomized controlled trial evaluating metformin pre-treatment and co-administration in non-obese insulin-resistant women with polycystic ovary syndrome treated with controlled ovarian stimulation plus timed intercourse or intrauterine inseminatio

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590500463360

Sequential treatment of metformin and clomiphene citrate in clomiphene-resistant women with polycystic ovary syndrome: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590500463360

Metformin does not enhance ovulation induction in clomiphene resistant polycystic ovary syndrome in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590500463360

Medical vs. surgical treatment for clomiphene citrate-resistant women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590500463360

Insulin-sensitizing agents as primary therapy for patients with polycystic ovarian syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590500463360

Effects of metformin and rosiglitazone, alone and in combination, in nonobese women with polycystic ovary syndrome and normal indices of insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590500463360

Hypersecretion of luteinizing hormone and the polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590500463360

Influence of serum luteinising hormone concentrations on ovulation, conception, and early pregnancy loss in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590500463360

Hypersecretion of luteinising hormone, infertility, and miscarriage

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590500463360

Recurrent early miscarriage and polycystic ovaries

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590500463360

Hypersecretion of luteinizing hormone and ovarian steroids in women with recurrent early miscarriage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590500463360

Influence of past reproductive performance on risk of spontaneous abortion

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590500463360

Increased prevalence of insulin resistance in women with a history of recurrent pregnancy loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590500463360

The pathogenesis of infertility and early pregnancy loss in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590500463360

Clomiphene citrate--end of an era? A mini-review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590500463360

Pregnancy outcomes with increased clomiphene citrate dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590500463360

A trial of a new regimen with clomiphene citrate administration to reduce the antiestrogenic effects on reproductive end organs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590500463360

Ovulation induction in women with polycystic ovary syndrome: randomized trial of clomiphene citrate versus low-dose recombinant FSH as first line therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590500463360

Prospective parallel randomized, double-blind, double-dummy controlled clinical trial comparing clomiphene citrate and metformin as the first-line treatment for ovulation induction in nonobese anovulatory women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590500463360

The management of infertility associated with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590500463360

Low-dose FSH therapy for anovulatory infertility associated with polycystic ovary syndrome: rationale, results, reflections and refinements

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590500463360

Combined luteinizing hormone releasing hormone analogue and exogenous gonadotrophins for the treatment of infertility associated with polycystic ovaries

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590500463360

The use of GnRH antagonists in ovarian stimulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590500463360

The LHRH antagonist cetrorelix: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590500463360

Concurrent ganirelix and follitropin beta therapy is an effective and safe regimen for ovulation induction in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590500463360

Comparison of GnRH agonists and antagonists in assisted reproduction cycles of patients at high risk of ovarian hyperstimulation syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590500463360

The effect of age on the ovarian response to gonadotropin and on pregnancy rate in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590500463360

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590500463360

Can assisted reproduction technology compensate for the natural decline in fertility with age? A model assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590500463360

Use of an aromatase inhibitor for induction of ovulation in patients with an inadequate response to clomiphene citrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590500463360

Comparison of two aromatase inhibitors in women with clomiphene-resistant polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590500463360

Aromatase inhibition reduces the dose of gonadotropin required for controlled ovarian hyperstimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590500463360

Letrozole-induced polycystic ovaries in the rat: a new model for cystic ovarian disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590500463360

A randomized single-blind controlled trial of letrozole as a low-cost IVF protocol in women with poor ovarian response: a preliminary report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590500463360

A randomized trial of letrozole versus clomiphene citrate in women undergoing superovulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590500463360

Pregnancy outcome after the use of an aromatase inhibitor for ovarian stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590500463360

10.1080/09513590500463360

21 January 2018

Identifiers

DOI

1 reference

24 July 2017

1 reference

PubMed ID

16390783